2009 Partnering for Cures Highlights
The inaugural Partnering for Cures meeting provided the life sciences community with a platform to facilitate collaboration. Participants said it was "game-changing." Here are some outcomes:
• A large pharmaceutical company provided a matching grant to support research championed by a small medical research foundation.
• A biotechnology company and a nonprofit foundation are collaborating on a preclinical stage cancer program.
• Two premier philanthropists teamed up to develop innovative cancer research.
• A sustainable alliance was built between a medical research foundation and pharmaceutical company that's now yielding probable research partnerships.
• A nonprofit organization developed a grant program in response to needs for better biomarkers articulated by other nonprofit attendees.
• Philanthropic funders of medical research said that the meeting cut their due diligence process in half, allowing for more accelerated grant funding and program development.
"Attending the Partnering for Cures conference [2009] was a catalyst for our organization receiving a $250,000 matching grant from the Johnson & Johnson Corporate Office of Science and Technology. These new funds will allow us to fund one additional "Rising Star" scientist to continue our critical research."

– Matt Bowman, co-founder, International Mental Health Research Organization
Inaugural Program Highlights
View Now:
Opening Plenary: Paving the Way to Cross-Sector Collaborations
A Conversation Between Mike Milken and Pfizer CEO Jeffrey Kindler
Breakthrough Science: Plenary with Some of Medical Research's Most Forward-Thinking Leaders
Lunch Plenary - A Conversation between Mike Milken, Gail Cassell, and Joshua Sharfstein
2009 Partnering for Cures Program Agenda
 
Meeting Coverage Highlight:
Maria Bartiromo, anchor of CNBC's Closing Bell, speaks with Dr. Joshua Sharfstein, FDA deputy commissioner; Dr. Gail Cassell, Eli Lilly & Co. vice president for scientific affairs and Michael Milken, FasterCures chairman about preventing chronic disease, investing in innovation, putting a cost on cures, ensuring access, and forecasting the promise of healthcare reform.
View interview »
The inaugural Partnering for Cures meeting brought together philanthropy, medical research foundations, and the biotechnology and pharmaceutical industries in an effort to forge strategic collaborations key to the timely development of new medical solutions.

2009 Partnering for Cures Highlights
> 600 medical research executives, scientists, policy makers, and funders from more than 575 organizations explored novel development and funding approaches
82 speakers, among the most forward-thinking leaders engaged in dynamic and candid discussion of the issues
42 medical research foundations presented their research and development strategies
92% participants surveyed found the conference to be well organized
>500 one-on-one meetings scheduled through the partnering database
1 in 2 participated in partnering meeting (s)
• 65% led to new relationships
• 75% led to valuable information exchange
2009 Links
For media inquiries, please contact:

Cecilia Arradaza
Communications Director
FasterCures
p // 202-336-8912
e // carradaza@fastercures.org
Terms Of Use  //  Privacy Statement
© 2011 by Partnering for Cures